TY - JOUR
T1 - Recommendations for screening and early detection of common cancers in India
AU - Rajaraman, Preetha
AU - Anderson, Benjamin O.
AU - Basu, Partha
AU - Belinson, Jerome L.
AU - D'Cruz, Anil
AU - Dhillon, Preet K.
AU - Gupta, Prakash
AU - Jawahar, Tenkasi S.
AU - Joshi, Niranjan
AU - Kailash, Uma
AU - Kapambwe, Sharon
AU - Katoch, Vishwa Mohan
AU - Krishnan, Suneeta
AU - Panda, Dharitri
AU - Sankaranarayanan, R.
AU - Selvam, Jerard M.
AU - Shah, Keerti V.
AU - Shastri, Surendra
AU - Shridhar, Krithiga
AU - Siddiqi, Maqsood
AU - Sivaram, Sudha
AU - Seth, Tulika
AU - Srivastava, Anurag
AU - Trimble, Edward
AU - Mehrotra, Ravi
N1 - Publisher Copyright:
© 2015 Elsevier Ltd.
PY - 2015/7/1
Y1 - 2015/7/1
N2 - Cancers of the breast, uterine cervix, and lip or oral cavity are three of the most common malignancies in India. Together, they account for about 34% of more than 1 million individuals diagnosed with cancer in India each year. At each of these cancer sites, tumours are detectable at early stages when they are most likely to be cured with standard treatment protocols. Recognising the key role that effective early detection and screening programmes could have in reducing the cancer burden, the Indian Institute for Cytology and Preventive Oncology, in collaboration with the US National Cancer Institute Center for Global Health, held a workshop to summarise feasible options and relevant evidence for screening and early detection of common cancers in India. The evidence-based recommendations provided in this Review are intended to act as a guide for policy makers, clinicians, and public health practitioners who are developing and implementing strategies in cancer control for the three most common cancers in India.
AB - Cancers of the breast, uterine cervix, and lip or oral cavity are three of the most common malignancies in India. Together, they account for about 34% of more than 1 million individuals diagnosed with cancer in India each year. At each of these cancer sites, tumours are detectable at early stages when they are most likely to be cured with standard treatment protocols. Recognising the key role that effective early detection and screening programmes could have in reducing the cancer burden, the Indian Institute for Cytology and Preventive Oncology, in collaboration with the US National Cancer Institute Center for Global Health, held a workshop to summarise feasible options and relevant evidence for screening and early detection of common cancers in India. The evidence-based recommendations provided in this Review are intended to act as a guide for policy makers, clinicians, and public health practitioners who are developing and implementing strategies in cancer control for the three most common cancers in India.
UR - http://www.scopus.com/inward/record.url?scp=84937431549&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84937431549&partnerID=8YFLogxK
U2 - 10.1016/S1470-2045(15)00078-9
DO - 10.1016/S1470-2045(15)00078-9
M3 - Review article
C2 - 26149887
AN - SCOPUS:84937431549
SN - 1470-2045
VL - 16
SP - e352-e361
JO - The Lancet Oncology
JF - The Lancet Oncology
IS - 7
ER -